HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma

Bibliographic Details
Main Authors:	Liu, Y J, Shen, D, Yin, X, Gavine, P, Zhang, T, Su, X, Zhan, P, Xu, Y, Lv, J, Qian, J, Liu, C, Sun, Y, Qian, Z, Zhang, J, Gu, Y, Ni, X
Format:	Online
Language:	English
Published:	Nature Publishing Group 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950883/

Similar Items